LillyDirect Self Pay
LillyDirect is Eli Lilly’s direct-to-patient pharmacy. Its Self Pay program sells Lilly medications for cash, bypassing insurance entirely. This page explains how the pricing is structured and what conditions attach to it.
Pricing data as of .
Who can use this, and what to watch for
Every point below comes from the same data file that drives the price table, so it cannot drift from the figures on this page.
Worth knowing
- Requires a valid prescription from a licensed healthcare provider.
- Paying cash bypasses your insurance, so what you spend here does not count toward your deductible or your out-of-pocket maximum.
- Mounjaro is approved for type 2 diabetes, not for weight management. Coverage and program eligibility follow the diabetes indication.
- Ozempic is approved for type 2 diabetes, not for weight management. Coverage and program eligibility follow the diabetes indication.
- Medicaid GLP-1 coverage is state-by-state. A federal program reported for 2026 negotiates terms on behalf of state Medicaid agencies, but participation is voluntary and what you pay depends on your own state. There is no national Medicaid price for these medications and this site does not publish one.
- IMPORTANT AND UNRESOLVED: sources disagree about whether Medicare and Medicaid beneficiaries may buy through this cash-pay program at all. One reading excludes government-programme beneficiaries outright; another permits anyone with a prescription who chooses to pay cash. We could not settle it, so we are neither hiding this pathway from you nor telling you it is available. Call the program and ask before you rely on it.
- A refill window is reported to apply at these doses: the reduced price is reported to require refilling within 45 days of your previous fill being delivered. What is reported to happen if you miss it is not a small penalty and it is not one number: it is reported to scale by dose, with the highest doses reaching roughly four figures a month. If a late refill is a realistic possibility for you, ask the programme for the exact penalty at your dose before you rely on any figure here.
- The reduced price at these doses is also reported to be restricted to the higher doses only, excluding the two starting doses. Confirm your dose is covered.
- At the two highest doses a lower price is reported to require refilling within 45 days of your previous fill being delivered. Miss that window and the price is reported to revert to the higher regular figure. If you are on 14.5 mg or 17.2 mg, ask the programme what happens if a refill is late before you rely on any figure here.
Cash-pay means exactly that
Buying through a manufacturer self-pay program means you are not using your insurance. That has a consequence people routinely miss: what you spend does not count toward your deductible or your annual out-of-pocket maximum. If you expect to hit either this year, the cheapest monthly price may not be the cheapest annual outcome.
A valid prescription is still required. A direct-pay program changes who you pay, not whether you need a prescriber.
Priced in tiers, not at one rate
Zepbound single-dose vials are filed in tiers rather than at a flat price, so the starter dose and the maintenance doses are different figures. Any page quoting one Zepbound price is wrong for most readers.
A refill-window condition has also been reported at the higher doses, requiring a refill within a set number of days to hold the reduced price. We have not been able to confirm that condition against Eli Lilly, and we flag it as a caveat rather than burying it, because if it is real it changes what you actually pay.
What LillyDirect cannot tell you
A manufacturer pharmacy is accurate about its own products and structurally incapable of telling you that a competitor’s medication or the federal platform is cheaper for you. That is not a criticism, it is the shape of the incentive.
This site has no such constraint and no relationship with Eli Lilly. Use the tool to see LillyDirect ranked against every alternative.
Every figure we hold for this pathway
| Medication | Pathway | Dose or tier | Monthly | Confidence | Source type | Verified | Source |
|---|---|---|---|---|---|---|---|
| Zepbound | LillyDirect Self Pay | 2.5mg | Not verified | Not verified | Primary, manufacturer | 2026-07-30 | Open |
| Zepbound | LillyDirect Self Pay | 5mg | Not verified | Not verified | Primary, manufacturer | 2026-07-30 | Open |
| Zepbound | LillyDirect Self Pay | all other doses | Not verified | Not verified | Primary, manufacturer | 2026-07-30 | Open |
| Mounjaro | LillyDirect Self Pay | any | Not verified | Not verified | Primary, manufacturer | 2026-07-30 | Open |
| Foundayo | LillyDirect Self Pay | 0.8mg | Not verified | Not verified | Primary, manufacturer | 2026-07-30 | Open |
| Foundayo | LillyDirect Self Pay | 2.5mg | Not verified | Not verified | Primary, manufacturer | 2026-07-30 | Open |
| Foundayo | LillyDirect Self Pay | mid doses | Not verified | Not verified | Primary, manufacturer | 2026-07-30 | Open |
| Foundayo | LillyDirect Self Pay | top doses | Not verified | Sources conflict | Primary, manufacturer | 2026-07-30 | Open |
Compare it against everything else
A single pathway in isolation cannot tell you whether it is your cheapest option. Use the tool to rank this pathway against every other one for your medication, your insurance situation and your dose.